Andy Jassy, CEO of AWS, told Jim Cramer on 'Mad Money' that it's easy to lower prices, but it's harder to be able to afford the cuts.
Amazon Web Services CEO Andy Jassy said that it's fairly simple to lower the costs of various public cloud tools that it offers to customers.
Other key areas where Amazon tries to stay ahead of the competition include geographic reach and the variety of tools that are available. "I remember in 2007, 2008, when we had the recession, there were all of these very gloomy emails sent from a lot of venture capitalists, saying, 'Don't expect to get funded,'" Jassy said."But actually, the number of start-ups kept growing, because as opposed to having to go raise money to pay for data centers and servers, people can try several instantiations of their idea on top of AWS.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
3 Things Coca-Cola, AWS And Smartsheet Taught Me About InnovationIn today’s market, companies that are not constantly evolving or changing go extinct very quickly. Back in 1950, the average age of a company on the S&P 500 was 60 years old; today, it’s 20.
Read more »
3 Things Coca-Cola, AWS And Smartsheet Taught Me About InnovationIn today’s market, companies that are not constantly evolving or changing go extinct very quickly. Back in 1950, the average age of a company on the S&P 500 was 60 years old; today, it’s 20.
Read more »
Andy Anderson, former drummer with the Cure, dies at 68Anderson, former drummer with thecure announced last week that he was battling Stage 4 cancer, saying, “There is no way of returning back from that.”
Read more »
MongoDB shares plunge on concerns that Lyft could be moving to rival Amazon serviceAmazon said on Tuesday that Lyft is going 'all-in' with AWS, and an analyst raised concerns that Lyft is migrating away from MongoDB.
Read more »
'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA Chief saysRebates are a favorite target of pharmaceutical companies, who say pharmaceutical benefit managers extract huge discounts but keep them for themselves instead of sharing the savings with patients.
Read more »